Search research articles
Contact Us
Filters
Showing results (91-100 of 99) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 99 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2016
Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial
Yanfeng Hu, Changming Huang, Yihong Sun, et al.
JAMA
|
May 29, 2019
Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer: The CLASS-01 Randomized Clinical Trial
Jiang Yu, Changming Huang, Yihong Sun, et al.
JAMA Network Open
|
July 27, 2021
Comparison of Survival and Patterns of Recurrence in Gastric Neuroendocrine Carcinoma, Mixed Adenoneuroendocrine Carcinoma, and Adenocarcinoma
Jianxian Lin, Yajun Zhao, Yanbing Zhou, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
September 11, 2020
Multi-institutional development and validation of a nomogram to predict recurrence after curative resection of gastric neuroendocrine/mixed adenoneuroendocrine carcinoma
Hualong Zheng, YaJun Zhao, Qingliang He, et al.
Frontiers in Oncology
|
October 22, 2019
In-Hospital Mortality Risk Model of Gastric Cancer Surgery: Analysis of a Nationwide Institutional-Level Database With 94,277 Chinese Patients
Zhouqiao Wu, Huimin Cheng, Fei Shan, et al.
Science Bulletin
|
December 20, 2023
Clinical landscape and prognosis of patients with gastric cancer liver metastases: A nation-wide multicenter cohort study in China (RECORD study)
Yunhe Gao, Hongqing Xi, Liang Shang, et al.
The Lancet. Oncology
|
July 12, 2021
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
Xiaotian Zhang, Han Liang, Ziyu Li, et al.
The Lancet. Oncology
|
February 14, 2025
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial
Xiaotian Zhang, Han Liang, Ziyu Li, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
July 11, 2025
Long-term outcomes of laparoscopic distal gastrectomy for locally advanced gastric cancer: An individual patient data meta-analysis of KLASS-02 and CLASS-01 randomized controlled trials
Yanfeng Hu, Woo Jin Hyung, Huilin Huang, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 99) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 99 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2016
Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial
Yanfeng Hu, Changming Huang, Yihong Sun, et al.
JAMA
|
May 29, 2019
Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer: The CLASS-01 Randomized Clinical Trial
Jiang Yu, Changming Huang, Yihong Sun, et al.
JAMA Network Open
|
July 27, 2021
Comparison of Survival and Patterns of Recurrence in Gastric Neuroendocrine Carcinoma, Mixed Adenoneuroendocrine Carcinoma, and Adenocarcinoma
Jianxian Lin, Yajun Zhao, Yanbing Zhou, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
September 11, 2020
Multi-institutional development and validation of a nomogram to predict recurrence after curative resection of gastric neuroendocrine/mixed adenoneuroendocrine carcinoma
Hualong Zheng, YaJun Zhao, Qingliang He, et al.
Frontiers in Oncology
|
October 22, 2019
In-Hospital Mortality Risk Model of Gastric Cancer Surgery: Analysis of a Nationwide Institutional-Level Database With 94,277 Chinese Patients
Zhouqiao Wu, Huimin Cheng, Fei Shan, et al.
Science Bulletin
|
December 20, 2023
Clinical landscape and prognosis of patients with gastric cancer liver metastases: A nation-wide multicenter cohort study in China (RECORD study)
Yunhe Gao, Hongqing Xi, Liang Shang, et al.
The Lancet. Oncology
|
July 12, 2021
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
Xiaotian Zhang, Han Liang, Ziyu Li, et al.
The Lancet. Oncology
|
February 14, 2025
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial
Xiaotian Zhang, Han Liang, Ziyu Li, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
July 11, 2025
Long-term outcomes of laparoscopic distal gastrectomy for locally advanced gastric cancer: An individual patient data meta-analysis of KLASS-02 and CLASS-01 randomized controlled trials
Yanfeng Hu, Woo Jin Hyung, Huilin Huang, et al.
Page
of 10